CDEK
← All organizations

Calliditas Therapeutics

For profitWebsite ↗

Also known as: CALLIDITAS | Calliditas Therapeutics | Calliditas Therapeutics AB | Calliditas Therapeutics Suisse SA | Pharmalink | Pharmalink AB | Pharmalink AB, Stockholm, Sweden | Pharmalink International Ltd.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Jun 1, 2004

First marketed drug

Dec 15, 2021

Last known activity

Dec 15, 2024

Timeline

2000s

  1. Jun 1, 2004

    Calliditas Therapeutics— Founded

2020s

  1. Aug 13, 2020

    Genkyotex Innovation SAS— Acquired

  2. Dec 15, 2021

    budesonide— Marketing Organization

  3. Dec 15, 2021

    budesonide— NDA Secondary Org

Drugs by trial phase (10 distinct, 17 trials)

Phase 4 (1 own, 0 via acquisition)

Phase 3 (0 own, 1 via acquisition)

Phase 2 (1 own, 2 via acquisition)

Phase 1 (1 own, 2 via acquisition)

Other trials (2 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Subsidiaries (1 direct, 2 total across the full acquisition tree)

Recent trials (12)

Details

Founded
Stockholm, SE Jun 1, 2004
Last known activity
Dec 15, 2024